Keynote Speakers Time Topic Presenter 1:00pm Opening: GHP website Prof. Dr. Heinz Josef-Schmitt Mainz, Germany 1:05pm COVID Summary (45 mins) Prof. Robert Booy Sydney, Australia 1:50pm Measles Elimination Prof...
The COVID pandemic showed lack of preparedness in many public health areas all over Europe. One such gap – often overlooked – is the lack of tools to rapidly conduct clinical studies on new vaccines. This gap has...
Background Most TBE virus infections remain asymptomatic; but when the infection is symptomatic, the disease can manifest with fever and can often involve the central nervous system (CNS) which leads to tick-borne...
Background During the last 30 years, the number of reported TBE cases in Europe has increased by more than 193%, despite two effective TBE vaccines (FSME Immune and Encepur) being available. The raison for this increase...
The Advisory Committee on Immunization Practices (ACIP) voted on February 23, 2022, to recommend a TBE vaccine for people 12 months of age and older, who are travelling to TBE-endemic areas. TBE is a viral infection of...
Introduction As of January 30, 2022, Cameroon has recorded 1,102 cholera cases across five Regions. The outbreak has already claimed the lives of 32 persons. These figures were reported by the Cameroon Ministry of...
The Covid-19 pandemic has understandably dominated the news cycle for almost 2 years now. As we hopefully get past the Omicron variant, it’s important not to lose sight of the currently over 7 million infections with...
In 2020–2021, a group of researchers from Gomel State Medical University conducted a prospective comparative clinical research that clearly demonstrates the differences in immunogenicity and reactogenicity of Sputnik V...
Background In Sweden, the number of TBE cases have dramatically increased over the past three decades, with an average of 328 notified cases annually during the past 5 years (2017–2021), which corresponds to an...